Interaction between a vaccine and a drug has been reported only with influenza vaccine and four drugs (aminopyrine, phenytoin sodium, theophylline, and warfarin sodium), and with BCG vaccine and theophylline. Some of these interactions still are unconfirmed.
The underlying mechanism of the interaction is thought to be due to the vaccine (as an interferon-inducer) inactivating the hepatic cytochrome P-450 system; this results in depressed drug metabolism and reduced clearance. Because this is a nonspecific mechanism it could occur with other vaccines and it is possible that other vaccine-drug interactions are unrecognized.
The clinical significance of vaccine-drug interactions is not fully determined; available evidence suggests that adverse reactions to warfarin or theophylline are rare after influenza vaccination and their possibility should not deter physicians from vaccinating those elderly patients at risk from influenza. Physicians should, however, monitor the response of these patients to medication in the immediate period following vaccination in case an adverse reaction occurs.
CodyCLBaraffLJCherryJDMarcySMManclarkCR. Nature and rate of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics1981; 68: 650–60.
5.
KanaiK. Japan's experience in pertussis epidemiology and vaccination in the past 30 years. Jpn J Med Sci Biol1980; 33: 107–43.
6.
Pertussis—England and Wales.Morb Mortal Wkly Rep1982; 31: 629–31.
7.
MillerDLAldersladeRRossEM. Whooping cough and whooping cough vaccine. The risks and benefits debate. Epidemiol Rev1982; 4: 1–24.
8.
Diphtheria, tetanus and pertussis: guidelines for vaccine prophylaxis and other preventive measures.Morb Mortal Wkly Rep1981; 30: 393–407.
9.
Report of the Committee on Infectious Diseases, 19th ed.Evanston, IL: American Academy of Pediatrics, 1982.
10.
FulginitiVA. Pertussis disease, vaccine, and controversy (editorial). JAMA1984; 251: 251.
11.
RobinsonRJ. The whooping-cough immunisation controversy. Arch Dis Child1981; 56: 577–80.
12.
GorodischerRKrasnerJMcDevittJJNolanJPYaffeSJ. Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem Pharmacol1976; 25: 351–3.
13.
FarquharDLooTLGuttermanJUHershEMLunaMA. Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol1976; 25: 1529–35.
14.
RentonKW. The deleterious effect of Bordetella pertussis vaccine and poly (rI.rC) on the metabolism and disposition of phenytoin. J Pharmacol Exp Ther1979; 208: 267–70.
15.
SoykaLEHuntWGKnightSEFosterRSJr. Decreased liver and lung drug metabolizing activity in mice treated withCorynebacterium parvum. Cancer Res1976; 36: 4425–8.
16.
SonnenfeldGHarnedCLThaniyavarnSHuffTMandelADNerlandDE. Type II interferon inducing and passive transfer depress the murine cytochrome P-450 drug metabolism system. Antimicrob Agents Chemother1980; 17: 969–72.
17.
KramerPMcClaineCJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med1981; 305: 1262–4.
18.
VesellES. Aminopyrine and antipyrine as tests of liver function. In: DavidsonCS. ed. Problems in liver diseases. New York: Stratton Intercontinental, 1979: 299–312.
19.
HepnerGWVesellES. Quantitative assessment of hepatic function by breath analysis after oral administration of [14C] aminopyrine. Ann Intern Med1975; 83: 632–8.
20.
GalizziJLongRGBillingBHSherlockS. Assessment of the (14C) aminopyrine breath test in liver disease. Gut1978; 19: 40–5.
21.
RentonKWManneringGJ. Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents. Biochem Biophys Res Commun1976; 73: 343–8.
22.
ManneringGJRentonKWAzharyRDeloriaLB. Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems. Ann NY Acad Sci1980; 350: 314–31.
23.
BarryDWMaynerREHochsteinHDComparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol1976; 104: 47–59.
24.
HunterRA. Status epilepticus: history, incidence and problems. Epilepsia1959/60;1: 162–8.
25.
LeppikIERamaniVSawchukRJGumnitRJ. Increased clearance of phenytoin during infectious mononucleosis. N Engl J Med1979; 300: 481–2.
26.
SawchukRJRectorTSFordiceJJLeppikIE. Effect of influenza vaccination on plasma protein concentrations. Ther Drug Monitor1979; 1: 285–8.
27.
KraemerMJFurukawaCTKoupJRShapiroGGPiersonWEBiermanCW. Altered theophylline clearance during an influenza B outbreak. Pediatrics1982; 69: 476–80.
28.
RentonKWGrayJDHallRI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J1981; 123: 288–90.
29.
WalkerSSchreiberLMiddelkampJN. Serum theophylline levels after influenza vaccination (letter). Can Med Assoc J1981; 125: 243–4.
GoldsteinRSCheungOTSeguinRLobleyGJohnsonAC. Decreased elimination of theophylline after influenza vaccination (letter). Can Med Assoc J1982; 126: 470.
32.
FischerRGBoothBHMitchellDQKibbeAH. Influence of trivalent influenza vaccine on serum theophylline levels. Can Med Assoc J1982; 126: 1312–3.
33.
StultsBMHashisakiPA. Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung-disease. West J Med1983; 139: 651–4.
34.
RentonKWGrayJD. Decreased elimination of theophylline after influenza vaccination (letter). Can Med Assoc J1982; 126: 470.
35.
GrayJDRentonKWHungOR. Depression of theophylline elimination following BCG vaccination. Br J Clin Pharmacol1983; 16: 735–7.
36.
PatriarcaPAKendalAPStricofRLWeberJAMeissnerMKDatenoB. Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents (letter). N Engl J Med1983; 308: 1601–2.
